SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories to sell Pithampur manufacturing facility to Rubicon Research

07 Jan 2025 Evaluate

Alkem Laboratories has entered into a business transfer agreement with Rubicon Research on January 6, 2025 to sell its manufacturing facility in Pithampur, Madhya Pradesh. The consideration received from the sale is Rs 149 crore. The sale is part of an ongoing initiative of networking strategy and optimisation of manufacturing facilities.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Alkem Laboratories Share Price

5576.80 -14.05 (-0.25%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×